Precision Aptamers Against a Native GPCR through Ligand-Guided Selection

preprint OA: closed
Full text JSON View at publisher

Abstract

G protein–coupled receptors (GPCRs) constitute the largest and most diverse class of membrane receptors encoded in the human genome. They detect a wide range of chemical and physical stimuli and transduce these signals into intracellular responses through highly regulated pathways. Reflecting their central role in physiology, GPCRs are among the most prominent targets in drug discovery. However, identifying ligands that recognize GPCRs in their native conformational and membrane context remains a significant challenge. Here, we report an expanded aptamer discovery platform based on ligand-guided selection (LIGS) to isolate aptamers against GPCRs in their native cellular state. Using the β 2 -adrenergic receptor (β 2 AR) as a model system and employing agonists and antagonists as competing ligands, we identified three aptamers with high specificity for β 2 AR. These aptamers exhibit selective binding to cell-surface β 2 AR, showing higher apparent affinity towards cell-membrane bound β 2 AR than toward the purified receptor, which is consistent with recognition of native receptor context. Beyond target recognition, we show that the selected aptamers induce rapid internalization, indicating functional engagement. Together, these findings establish ligand-guided selection as a generalizable strategy for the discovery of conformationally sensitive aptamers targeting GPCRs in their native membrane environments. Significance The ability to discover ligands for receptors that undergo dynamic conformational changes is essential for advancing targeted therapeutics. G protein–coupled receptors (GPCRs), among the most sought-after drug targets, exist in transient and heterogeneous conformational states that are difficult to replicate in purified or artificial systems. Here, we introduce a ligand discovery platform that leverages native receptor interactions with agonists and antagonists to enable the selection of nucleic acid ligands (aptamers) directly against GPCRs in their cellular context, eliminating the need for purified receptors. The resulting aptamers exhibit selective binding to membrane-bound receptors and display intracellular functionality, highlighting a broadly applicable strategy for discovering ligands that recognize and modulate GPCRs in their native environments.
Full text 2,388 characters · extracted from oa-doi-fallback · click to expand
Abstract G protein–coupled receptors (GPCRs) constitute the largest and most diverse class of membrane receptors encoded in the human genome. They detect a wide range of chemical and physical stimuli and transduce these signals into intracellular responses through highly regulated pathways. Reflecting their central role in physiology, GPCRs are among the most prominent targets in drug discovery. However, identifying ligands that recognize GPCRs in their native conformational and membrane context remains a significant challenge. Here, we report an expanded aptamer discovery platform based on ligand-guided selection (LIGS) to isolate aptamers against GPCRs in their native cellular state. Using the β2-adrenergic receptor (β2AR) as a model system and employing agonists and antagonists as competing ligands, we identified three aptamers with high specificity for β2AR. These aptamers exhibit selective binding to cell-surface β2AR, showing higher apparent affinity towards cell-membrane bound β2AR than toward the purified receptor, which is consistent with recognition of native receptor context. Beyond target recognition, we show that the selected aptamers induce rapid internalization, indicating functional engagement. Together, these findings establish ligand-guided selection as a generalizable strategy for the discovery of conformationally sensitive aptamers targeting GPCRs in their native membrane environments. Significance The ability to discover ligands for receptors that undergo dynamic conformational changes is essential for advancing targeted therapeutics. G protein–coupled receptors (GPCRs), among the most sought-after drug targets, exist in transient and heterogeneous conformational states that are difficult to replicate in purified or artificial systems. Here, we introduce a ligand discovery platform that leverages native receptor interactions with agonists and antagonists to enable the selection of nucleic acid ligands (aptamers) directly against GPCRs in their cellular context, eliminating the need for purified receptors. The resulting aptamers exhibit selective binding to membrane-bound receptors and display intracellular functionality, highlighting a broadly applicable strategy for discovering ligands that recognize and modulate GPCRs in their native environments. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00